Lung Cancer EVAN Study: Adjuvant Erlotinib Superior to Chemotherapy for R0-Stage III EGFR+ NSCLC Mar 29, 2023
Lung Cancer ORIENT-11 Asian Results: Applicability in West according to ICH- E5 Framework Mar 29, 2023
Lung Cancer ATTRACTION-2 Study: Nivolumab±ipilimumab vs. Placebo for HPD and Natural Disease Progression Mar 29, 2023
Lung Cancer GEMSTONE-301 PHASE III: Sugemalimab vs. Placebo in Chemoradiotherapy Patients Mar 28, 2023
